Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Asset Writedowns and Impairment (2024 - 2025)

Historic Asset Writedowns and Impairment for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to $31.0 million.

  • Genmab A's Asset Writedowns and Impairment rose 41666.67% to $31.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $32.0 million, marking a year-over-year increase of 8823.53%. This contributed to the annual value of $32.0 million for FY2025, which is 8823.53% up from last year.
  • Genmab A's Asset Writedowns and Impairment amounted to $31.0 million in Q4 2025, which was up 41666.67% from $1.0 million recorded in Q1 2025.
  • In the past 5 years, Genmab A's Asset Writedowns and Impairment registered a high of $31.0 million during Q4 2025, and its lowest value of $1.0 million during Q1 2025.